Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second‐line chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|11|1935-1941

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.11, 2015-11, pp. : 1935-1941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second‐line chemotherapy

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 1935-1941

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response of a Patient with Pleural and Peritoneal Mesothelioma after Second-Line Chemotherapy with Lipoplatin and Gemcitabine

By  

Oncology, Vol. 73, Iss. 5-6, 2008-06 ,pp. : 426-429

Karger

Access to resources Recommend Favorite

Relevance and Necessity of Studies on Second-Line Chemotherapy in Melanoma

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 527-528

Karger

Access to resources Recommend Favorite

Second-Line Chemotherapy in Advanced Bladder Cancer

By  

Urologia Internationalis, Vol. 64, Iss. 2, 2000-05 ,pp. : 61-69

Karger

Access to resources Recommend Favorite

Second-Line Chemotherapy in Recurrent Glioblastoma - Still Controversial

By  

Oncology Research and Treatment, Vol. 38, Iss. 7-8, 2015-07 ,pp. : 345-346

Karger

Access to resources Recommend Favorite